IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR Ardelyx to Present at the 10th Annual SVB Leerink Global Healthcare Conference Read more about Ardelyx to Present at the 10th Annual SVB Leerink Global Healthcare Conference Louise Chen Louise Chen Cantor Fitzgerald Ardelyx to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference Read more about Ardelyx to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference Ardelyx to Present at the Jefferies Virtual London Healthcare Conference Read more about Ardelyx to Present at the Jefferies Virtual London Healthcare Conference Ardelyx to Webcast Virtual Analyst Day Read more about Ardelyx to Webcast Virtual Analyst Day Ardelyx Reports Third Quarter 2020 Financial Results and Business Highlights Read more about Ardelyx Reports Third Quarter 2020 Financial Results and Business Highlights Ardelyx and Kyowa Kirin Highlight New Data Supporting the Clinical Safety and Efficacy of First-In-Class, Phosphate Absorption Inhibitor Tenapanor at ASN's Kidney Week 2020 Read more about Ardelyx and Kyowa Kirin Highlight New Data Supporting the Clinical Safety and Efficacy of First-In-Class, Phosphate Absorption Inhibitor Tenapanor at ASN's Kidney Week 2020 Ardelyx Launches 'Can We Do Better?' Campaign at ASN's Kidney Week 2020 Read more about Ardelyx Launches 'Can We Do Better?' Campaign at ASN's Kidney Week 2020 Ardelyx Announces Data Supporting Efficacy and Safety of Tenapanor, a First-in-Class Phosphate Absorption Inhibitor, to be Presented at ASN's Kidney Week 2020 Read more about Ardelyx Announces Data Supporting Efficacy and Safety of Tenapanor, a First-in-Class Phosphate Absorption Inhibitor, to be Presented at ASN's Kidney Week 2020 Ardelyx Announces FDA Acceptance for Filing of its New Drug Application of Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis Read more about Ardelyx Announces FDA Acceptance for Filing of its New Drug Application of Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis Pagination First page « First Previous page ‹ Previous … Page 9 Page 10 Page 11 Page 12 Current page 13 Page 14 Page 15 Page 16 Page 17 … Next page Next › Last page Last » Subscribe to FAQs Email Alerts Connect
Ardelyx to Present at the 10th Annual SVB Leerink Global Healthcare Conference Read more about Ardelyx to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Ardelyx to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference Read more about Ardelyx to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Ardelyx to Present at the Jefferies Virtual London Healthcare Conference Read more about Ardelyx to Present at the Jefferies Virtual London Healthcare Conference
Ardelyx Reports Third Quarter 2020 Financial Results and Business Highlights Read more about Ardelyx Reports Third Quarter 2020 Financial Results and Business Highlights
Ardelyx and Kyowa Kirin Highlight New Data Supporting the Clinical Safety and Efficacy of First-In-Class, Phosphate Absorption Inhibitor Tenapanor at ASN's Kidney Week 2020 Read more about Ardelyx and Kyowa Kirin Highlight New Data Supporting the Clinical Safety and Efficacy of First-In-Class, Phosphate Absorption Inhibitor Tenapanor at ASN's Kidney Week 2020
Ardelyx Launches 'Can We Do Better?' Campaign at ASN's Kidney Week 2020 Read more about Ardelyx Launches 'Can We Do Better?' Campaign at ASN's Kidney Week 2020
Ardelyx Announces Data Supporting Efficacy and Safety of Tenapanor, a First-in-Class Phosphate Absorption Inhibitor, to be Presented at ASN's Kidney Week 2020 Read more about Ardelyx Announces Data Supporting Efficacy and Safety of Tenapanor, a First-in-Class Phosphate Absorption Inhibitor, to be Presented at ASN's Kidney Week 2020
Ardelyx Announces FDA Acceptance for Filing of its New Drug Application of Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis Read more about Ardelyx Announces FDA Acceptance for Filing of its New Drug Application of Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis